Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/816Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Edited by Kulshreshtha, Alok K. | - |
| dc.contributor.author | Singh, Onkar N. | - |
| dc.contributor.author | Wall, Michael G. | - |
| dc.date.accessioned | 2026-10-23T07:18:31Z | - |
| dc.date.available | 2026-10-23T07:18:31Z | - |
| dc.date.issued | 2010 | - |
| dc.identifier.isbn | 978-1-4419-1087-5 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/816 | - |
| dc.description | xvi, 319 pages: illustrations; includes index | en_US |
| dc.description.abstract | This book provides a comprehensive overview of the scientific principles, formulation, development, evaluation, and manufacture of pharmaceutical suspensions. It examines the fundamentals of pharmaceutical disperse systems, suspension formulation principles, and the selection and functions of excipients, including surfactants and viscosity-enhancing agents. The text discusses the pharmaceutical development and preclinical evaluation of suspension dosage forms, with emphasis on particle size distribution, physical stability, drug bioavailability, pharmacokinetics, and analytical techniques used to characterize formulations. It also explores clinical trials, manufacturing scale-up, technology transfer, and regulatory requirements for ensuring the quality, safety, and efficacy of suspension products. In addition, the book addresses emerging technologies, particularly solid nanosuspensions and their applications in nanomedicine. Drawing on contributions from experts in academia, industry, and regulatory agencies, it serves as a valuable reference for pharmaceutical scientists, formulation researchers, manufacturing professionals, and pharmacy students involved in the development and production of safe, stable, and effective pharmaceutical suspension products. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Springer New York | en_US |
| dc.subject | Pharmaceutical suspensions | en_US |
| dc.subject | Pharmaceutical formulation | en_US |
| dc.subject | Suspension dosage forms | en_US |
| dc.subject | Pharmaceutical technology | en_US |
| dc.subject | Drug manufacturing | en_US |
| dc.subject | Disperse systems | en_US |
| dc.subject | Pharmaceutical excipients | en_US |
| dc.subject | Drug stability | en_US |
| dc.subject | Particle size distribution | en_US |
| dc.subject | Drug bioavailability | en_US |
| dc.subject | Pharmacokinetics | en_US |
| dc.subject | Pharmaceutical analysis | en_US |
| dc.subject | Preclinical evaluation | en_US |
| dc.subject | Clinical trials | en_US |
| dc.subject | Manufacturing scale-up | en_US |
| dc.subject | Technology transfer | en_US |
| dc.subject | Pharmaceutical quality control | en_US |
| dc.subject | Regulatory affairs | en_US |
| dc.subject | Nanosuspensions | en_US |
| dc.subject | Nanomedicine | en_US |
| dc.title | Pharmaceutical Suspensions: | en_US |
| dc.title.alternative | From Formulation Development to Manufacturing/ | en_US |
| dc.type | Book | en_US |
| Appears in Collections: | Pharmacy | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Kulshreshtha 2010, Pharmaceutical Suspensions.pdf | 5.85 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.